SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $939,400 | -41.6% | 20,000 | -7.0% | 0.29% | -32.9% |
Q1 2021 | $1,609,000 | +2.5% | 21,500 | -42.8% | 0.43% | -18.4% |
Q2 2020 | $1,570,000 | +45.8% | 37,600 | 0.0% | 0.52% | +6.3% |
Q1 2020 | $1,077,000 | -63.9% | 37,600 | -9.2% | 0.49% | -54.3% |
Q4 2019 | $2,983,000 | +32.9% | 41,400 | +158.8% | 1.08% | +3.7% |
Q3 2019 | $2,245,000 | -63.9% | 16,000 | -52.9% | 1.04% | -55.1% |
Q2 2019 | $6,224,000 | +15.1% | 33,996 | 0.0% | 2.31% | +15.5% |
Q1 2019 | $5,407,000 | +349.5% | 33,996 | +112.5% | 2.00% | +167.5% |
Q4 2018 | $1,203,000 | -30.5% | 15,996 | 0.0% | 0.75% | -9.2% |
Q3 2018 | $1,732,000 | -74.2% | 15,996 | -62.8% | 0.82% | -68.1% |
Q2 2018 | $6,726,000 | -40.7% | 42,996 | -39.0% | 2.58% | -41.6% |
Q1 2018 | $11,346,000 | +33.8% | 70,496 | +36.9% | 4.43% | +48.0% |
Q4 2017 | $8,481,000 | +700.8% | 51,496 | +203.0% | 2.99% | +625.7% |
Q3 2017 | $1,059,000 | -21.7% | 16,996 | 0.0% | 0.41% | -19.8% |
Q2 2017 | $1,353,000 | +12.0% | 16,996 | 0.0% | 0.51% | +11.3% |
Q1 2017 | $1,208,000 | +39.3% | 16,996 | 0.0% | 0.46% | +18.2% |
Q4 2016 | $867,000 | – | 16,996 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |